knowledge -WSS

knowledge

author：fashion 2025-09-27 22:47:49 - browse：5979

Boxes of Wegovy — pharma coverage from STAT — Carsten Snejbjerg/Bloomberg

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs.

Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. In turn, Novo Nordisk is buying three of Catalent’s fill-finish sites from the investment group for $11 billion. Novo Holdings manages the assets of the Novo Nordisk Foundation, which has a controlling stake in the pharmaceutical company.

Catalent has been involved in the production of Novo’s obesity treatment Wegovy. With the agreement, Novo will pick up sites that focus on filling drugs in Italy, Brussels, and Bloomington, Ind. All have already been doing work for Novo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Abortion policy in the spotlight at Republican debate

focus

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Intellia plays down concerns on accidental germline transmission

U.K. researchers warn about biases in medical devices, algorithms

Stop the failed accountable care organization experiment

Neuroscience’s long legacy of racism

Methadone treatment changes are coming. Do they go far enough?

focus

knowledge

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Meadows told special counsel he could not recall Trump ever declassifying Mar

As demand for Covid shots wanes, Moderna seeks its next success

Leading voice in opioid treatment defends methadone clinic system

Medical records are filled with copy

5 to watch: Tech startups trying to solve health care's staffing crisis

Affirmative action in medical school literally saved lives

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Wegovy improves function in certain heart failure patients

focus

App could help diagnose ear infections more accurately — and at home

PBMs are inflating the cost of generic drugs. They must be reined in

AstraZeneca to buy developer of next

AstraZeneca to buy developer of next

Leading voice in opioid treatment defends methadone clinic system

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

Wikipedia

focus

knowledge